New analysis in 2003 Cmaj (Canadian Medical Association Journal) http: // www.
"We believe that the federal government has a convincing claim to raise the additional income needed to implement a large-scale expansion of Canadian medicines," Drs writes. Michael Wolfson, Ottawa University's Faculty of Medicine and Law, and Steven Morgan, Population and Public Health Sciences, British Columbia University.
The implementation of the National Pharmacopoeia Program in 2020 would require public funding of $ 9.7 billion and savings of $ 13.5 billion in the private sector due to lower private insurance costs, according to the estimates of Parliament's budget.
The authors recommend a combination of federal income sources, including personal income tax (0.5 percentage points), corporate tax rates (1 percentage point) and GST (0.25 percentage points) relatively small increases.
For advanced policy-makers, advanced modeling tools can have an impact on the financing of national farmaradio programs.
"Without the National Pharmacopoeia by 2020, Canadians would be able to pay $ 4.2 billion more medicines than they would need in the context of a universal comprehensive public farmer plan," the authors write. "The question, then, is not whether Canada can afford the national fares, rather how the government can raise the necessary public revenue, and who would benefit billions of dollars as a result of net savings."
"How to pay for the National Pharmacopoeia" will be published on 26. November 2018.
Post-Podcast export ban: https: /
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of the news posted by EurekAlert! using the participating facilities or all data using the EurekAlert system.